25th week of 2019 patent applcation highlights part 8 |
Patent application number | Title | Published |
20190183730 | ADAPTER ASSEMBLY FOR ATTACHMENT TO A BOTTLE - Various embodiments of the present disclosure describe systems and methods for testing samples (e.g., biological samples, environmental samples, food samples etc.) for microbial contamination. For example, some embodiments describe an adapter assembly with a means to penetrate a septum of a collection vessel and permit gaseous communication between a headspace of the collection vessel and a sensor. In some embodiments, the gases in the headspace of the collection vessel can exit the collection vessel without contaminating the environment outside the system or allowing sample contamination. In some embodiments, the adapter assembly includes a membrane configured to prevent liquid in the collection vessel from contacting the sensor. In some embodiments, the adapter assembly can be used to access media inside the collection vessel for subculturing or aliquotting for another diagnostic process such as molecular diagnostics. | 2019-06-20 |
20190183731 | SOLID PHARMACEUTICAL PREPARATION PRINTING METHOD AND SOLID PHARMACEUTICAL PREPARATION PRINTER - A solid pharmaceutical preparation printing method in which printing is performed on successively-supplied solid pharmaceutical preparations by discharging ink from a nozzle of a printing device based on printing data, the printing data including standard printing data and rotated printing data created by rotating the standard printing data at a selected rotation angle, and the printing based on the rotated printing data being performed in addition to the printing based on the standard printing data. | 2019-06-20 |
20190183732 | DRUG DELIVERY DEVICE HAVING CONTROLLED DELIVERY AND CONFIRMATION - A drug delivery device includes a capsule, a logic circuit disposed within the capsule, and an actuator connected to the logic circuit and configured to expose an interior of the capsule to an exterior of the capsule upon activation by the logic circuit. | 2019-06-20 |
20190183733 | TABLET PRINTING APPARATUS AND TABLET PRINTING METHOD - According to one embodiment, a tablet printing apparatus includes a conveyor configured to convey tablets sequentially supplied while sucking and holding the tablets; a print head arranged to face the conveyor to perform printing on each of the tablets being conveyed; a detector arranged upstream of the print head to detect the posture of each of the tablets; and a print condition tester arranged downstream of the print head to check print condition on each of the tablets. Suction force applied to the tablets is reduced at least in an area from a detection position to a print condition check position than in other area. | 2019-06-20 |
20190183734 | Delivery Device and Storage System for Oropharyngeal Administration of Mother's Colostrum and Milk - A delivery system and method for storing and delivering colostrum or milk to an infant are provided. In one aspect, the system includes a syringe for delivering a dose of colostrum or milk, a swab container, and a swab. The swab is contained in the swab container and the swab container connected to the syringe. In another aspect, the delivery system includes a plurality of syringes for delivering a dose of colostrum or milk and a storage container for storing the plurality of syringes having the colostrum or milk therein. The method includes loading a first syringe with a dose of colostrum or milk and placing the loaded first syringe in a first slot in a storage container. The method further includes loading a second syringe with a dose of colostrum or milk and placing the loaded second syringe in a second slot in the storage container. | 2019-06-20 |
20190183735 | Dosage management system - This invention relates to a dosage management system that comprises a container including a box with an opening towards the top. The box has a first side with an opposing second side and a third side. The box has a pair of parallel grooves in the first side and second side and a tray inside the box. There is also provided a resilient sliding lid. The lid has two parallel opposing edges that slidingly engage the grooves. At least one of the edges and grooves has a catch and notch combination that engage when the lid is in a closed position. The grooves have a first incline or decline part connected to a substantially horizontal part which is again connected to a second incline or decline part. When opening the box, the lid is pushed down the lid then bending into the horizontal part, the notch and catch disengaging and the lid is moved to the third side to open the box. Closing the box is accomplished by pushing the lid back towards the closing position and the catch is urged into the notch due to the lid regaining its shape. | 2019-06-20 |
20190183736 | SYSTEM AND METHOD FOR MEDICINE MANAGEMENT - A system for medicine management includes: a terminal including an input unit for receiving the input of the types and quantities of medicines, a communication unit for transmitting the inputted information on the types and quantities of medicines to an electronic balance smart safe, a display unit for displaying the information on the types and quantities of medicines, and a control unit for controlling the overall operation; an electronic balance smart safe comprising a plurality of sensor units for sensing the weight of a medicine case, a communication unit for receiving the information on the types and quantities of medicines and transmitting to a server, a display unit for displaying the information on the types and quantities of the medicine cases, a control unit for controlling the opening and closing of the door; and a server for managing the electronic balance smart safe. | 2019-06-20 |
20190183737 | MEDICAL OBJECT DISTRIBUTION SYSTEM AND METHOD - A pneumatic tubing system for distribution of medical objects in a medical environment without a dedicated carrier. The system comprises a plurality of headwall stations, a sending or receiving station, at least one pump, and at least one controller. Each headwall station is adapted to be installed in a headwall structure proximate to a patient bedside. The sending or receiving station is connected to each of the headwall stations via pneumatic tubing. The at least one pump is adapted to create pressure differentiation within at least a subset of the pneumatic tubing. The at least one controller is adapted to selectively activate the at least one pump to route a medical object between the sending or receiving station and one of the headwall stations within the pneumatic tubing. | 2019-06-20 |
20190183738 | MONITORING DEVICE FOR MONITORING THE DELIVERY AND TAKING OF MEDICATION PILLS AND A MONITORING METHOD - A device is provided for monitoring the delivery and taking of medication pills by detecting both the passage of a pill and the covering of a pill outlet region, which is indicative of an active operation of the user to remove the pill from the pill outlet region. In this way, pill delivery can be monitored as well as an indication of actual pill taking. | 2019-06-20 |
20190183739 | SYSTEM FOR AUTHORIZED DISPENSING OF MEDICINES - A portable compact scaled-down programmable system for authorized dispensing of medicines is illustrated. The system includes at least one enclosure, a dispenser unit having an integrated cap and a plurality of dispensing slots, adapted to facilitate dispense of at least one medicine to an authentic user. The system further includes a driving mechanism for the upward and downward movement of the dispenser unit, a control unit to facilitate controlled functioning of functional units of the system, a primary sensor unit to facilitate the identification and authorization, a power supply unit, a micro-USB, a GNSS module, a set of status indicators having a liquid crystal display, a speaker, a vibrator and a LED, a set of knobs, and a communication facilitator. Further, the system can be operated either in stand-alone mode and or in paired mode. The system is configured to include a plurality of internet of things [IoT] modules. | 2019-06-20 |
20190183740 | METHOD FOR STIRRING MILK POWDER SOLUTION AND STIRRING TYPE FEEDING-BOTTLE - Disclosed are a method for stirring milk powder solution and a stirring type feeding-bottle. The method comprising: driving a counterweight head ( | 2019-06-20 |
20190183741 | METHODS AND KITS FOR INSERTING A TUBE THROUGH THE NASOPHARYNX OF A PATIENT - Methods of inserting a tube through the nasopharynx of a patient are disclosed. Kits for inserting a tube through the nasopharynx of a patient are also disclosed. Methods of making kits for inserting a tube through the nasopharynx of a patient are further disclosed. | 2019-06-20 |
20190183742 | Fluorsecent Nanoparticle Compositions for Dental Bonded Restorations - Fluorescent nanoparticle compositions and methods of used for dental bonded restorations are provided herein. | 2019-06-20 |
20190183743 | ANHYDROUS, ANTIPERSPIRANT COMPOSITION HAVING IMPROVED STABILITY - The subject of the present application is an antiperspirant composition for personal body care having improved stability of the suspension contained, which contains a mixture of at least one oil, rice starch, at least one hydrophobically modified clay mineral and an antiperspirant active substance in the form of spherical particles. | 2019-06-20 |
20190183744 | METHODS OF MAKING COLORED WET WIPES, APPARATUSES THEREFOR, AND PRODUCTS - Disclosed are systems and methods for manufacturing colored wet wipes that avoid assembling colored fibers. The methods comprise preparing nonwovens from non-colored fibers, wetting the nonwovens with a functional liquid and a colorant (together or separately) to produce colored wet wipes, and packaging the wet wipes in a wet state. | 2019-06-20 |
20190183745 | MANUFACTURING METHOD OF PRESERVATIVE-FREE FACIAL MASK AND PROCESS EQUIPMENT THEREOF - The invention discloses a manufacturing method of a preservative-free facial mask and process equipment thereof. The method includes preparing distilled water with boiling point of 80-100° C., and reserving at a constant temperature; transporting the distilled water into a mixing agitator, cooling to 45-55° C.; weighing a facial mask powder into a drying mixer and mixing; turning on the mixing agitator, stirring the distilled water, adding the facial mask powder and a facial mask liquid material, stirring to form a paste liquid; importing the paste liquid into a colloid grinder, and forming a facial mask slurry; transporting into a coating machine, spreading the facial mask slurry onto surface of non-woven cloth to form facial mask slurry layer; drying the non-woven cloth, and performing instantaneous high-temperature sterilization and rolling up; slicing, moulding and packaging. The invention protects the human skin from being harmed and has a better effect without containing preservatives. | 2019-06-20 |
20190183746 | GEL COMPOSITION, SHEET, AND PRODUCTION METHOD THEREFOR - Provided is a gel composition including a partial degradation product of the galactose moiety of galactoxyloglucan, a compound that is a mixture of one kind or two or more kinds selected from magnesium salt, calcium salt, aluminum salt, and sodium salt, and an aqueous solvent. | 2019-06-20 |
20190183747 | AEROSOL ANTIPERSPIRANT METHODS - An aerosol antiperspirant product method of manufacture is provided, in which the time between the final milling of an antiperspirant composition and its filling into a spray device is at most 2 hours. | 2019-06-20 |
20190183748 | Silica Abrasives with High Stannous Fluoride Compatibility - This invention relates to dentifrice compositions comprising stannous fluoride and a silica abrasive having a N | 2019-06-20 |
20190183749 | Method Of Protecting Teeth Against Erosion - Disclosed are methods of treating and protecting teeth against erosion by use of oral compositions comprising polymeric mineral surface active agents, metal ions such as stannous and zinc and combinations thereof The present methods provide improved resistance of teeth to erosive demineralization or dissolution and prevention of tooth damage by subsequent exposure of teeth to erosive chemicals such as acidic foods and beverages. | 2019-06-20 |
20190183750 | THICKENED OXIDATION COMPOSITION - The present disclosure relates to an oxidising agent composition (M2), a packaging unit (kit of parts) comprising an agent for oxidative hair dyeing (M1) (dye component) and the oxidising agent composition (M2), a method for oxidative hair dyeing with use of the oxidising agent composition (M2), and the use of the oxidising agent composition for oxidative hair dyeing, for oxidative bleaching or lightening, and as fixing agent in a method for permanent shaping. | 2019-06-20 |
20190183751 | Pigment Compositions - The instant disclosure relates to a composition for topical application to the skin comprising a first pearlescent uncoated pigment having an average particle size of 25 um or less; a second pearlescent pigment having an average particle size of 25 um or less, completely or partially coated with one or more layers of metal oxides; a first mica having an average size of 42 um or less, completely or partially coated with one or more layers of red iron oxide; and a second mica having an average size of 25 um or less, completely or partially coated with one or more layers of titanium dioxide. It also relates to methods of using said compositions. | 2019-06-20 |
20190183752 | AGENT FOR CHANGING THE COLOR OF KERATIN-CONTAINING MATERIALS HAVING AT LEAST ONE ALCOHOL, A MODIFIED CLAY MINERAL AND A COLOR PIGMENT - The present disclosure relates to cosmetic agents for changing the color of keratinic materials, in particular human hair, containing
| 2019-06-20 |
20190183753 | RESIDUE-MINIMIZED ANTIPERSPIRANT COMPOSITION WITH IMPROVED SKIN FEEL - The present disclosure relates to substantially anhydrous sweat-suppressing compositions which leave minimal residues on textiles and at the same time result in an improved skin feel after application, containing combinations of rice starch and cornstarch or maize amylopectin, volatile and non-volatile oils, and at least one sweat-suppressing active agent. | 2019-06-20 |
20190183754 | High SPF, Photoprotective Anhydrous Zinc Oxide Sunscreen Compositions - A broad spectrum, anhydrous sunscreen composition having an SPF value of at least 50 that (x) does not contain an organic sunscreen active that absorbs ultraviolet radiation and (y) contains only a physical sunscreen active ingredient, Zinc Oxide, having an average particle size of greater than about 100 nanometers, the composition being comprised of: (a) at least one SPF-boosting emollient selected from the group consisting of Octyldodecyl Neopentanoate, Butyl Octyl Salycilate, and Cetyl Dimethicone; (b) at least one powder that provides protection to the skin from photodamage induced by exposure to ultraviolet radiation; (c) at least one powder that provides protection of the skin from photodamage induced by exposure to infrared radiation; (d) at least one film-forming polymer, and at least one bulking agent or binding agent. | 2019-06-20 |
20190183755 | Oral Care Composition Containing Zinc Salts and Calcium Carbonate - The present invention provides an oral care composition comprising: (a) a first composition comprising a silica abrasive and a first zinc compound selected from zinc citrate, zinc chloride, zinc acetate, zinc lactate, zinc salicylate, zinc sulfate, and zinc nitrate; and (b) a second composition comprising a calcium carbonate abrasive; wherein the first composition and/or the second composition further comprises a second zinc compound selected from zinc oxide, zinc carbonate and zinc tartrate; and wherein the oral care composition optionally further comprises from 0.1 to 1.75 weight % of a tartar control agent, based on the total weight of the oral care composition. | 2019-06-20 |
20190183756 | ZINC OXIDE-CONTAINING COMPOSITE PARTICLES, ULTRAVIOLET-SHIELDING COMPOSITION, AND COSMETIC - Zinc oxide-containing composite particles of the present invention each include: a dense matrix formed of silica and a polysilsesquioxane; and zinc oxide particles dispersed within the matrix. The content of the polysilsesquioxane in the matrix is 30 mass % to 70 mass %. The zinc oxide-containing composite particles of the present invention have high acid resistance and are capable of maintaining acid resistance even upon contact with water. | 2019-06-20 |
20190183757 | Dentifrice Including Zinc and Blue Dye or Pigment - A whitening dentifrice composition includes a blue coloring agent, a zinc salt, and an orally acceptable vehicle. The blue coloring agent is selected from the group consisting of a blue pigment and a blue dye. The blue pigment has a blue to blue-violet color with a hue angle in the CIELAB system ranging from 200 degrees to 320 degrees. The whitening dentifrice composition provides a greater whitening benefit to a tooth surface in comparison to a dentifrice composition that does not contain the zinc salt. | 2019-06-20 |
20190183758 | LIQUOR-BASED UNDERARM DEODORANT - An underarm deodorant has a solvent, an antiseptic component, and a potable alcoholic component having a distinctive fragrance, taste, or both. The underarm deodorant can also include an antiperspirant component and a chemical pheromone. The antiseptic and alcoholic components can be encapsulated in time-release polymer enclosures. The alcohol component can be in the form of beer, wine, whiskey, vodka, brandy, vermouth, bitters, champagne, anise, aperitifs, absinthe, scotch, rye, gin, rum, bourbon, tequila, and other liquors, cognac, or liqueurs combined to create not only the odor of such liquors, but taste as well. | 2019-06-20 |
20190183759 | Active Agent and Method for Reducing Malodor - An active agent to reduce malodor associated with a short or medium chain volatile fatty acid, the active agent including an oleic fatty chain molecule having one or more hydroxide head groups. | 2019-06-20 |
20190183760 | MEDICAMENT AND COSMETIC COMPOSITION COMPRISING RESORCINOL DERIVATIVES - The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation. | 2019-06-20 |
20190183761 | OXIDATIVE HAIR DYEING AGENT HAVING REDUCED HAIR DAMAGE AND IMPROVED DYEING PROPERTIES - The subject of present disclosure is an oxidation dyeing agent for the oxidative color change of keratinous fibers, in particular human hair, comprising at least one alkalizing agent, at least one oxidation dye precursor of a developer type and at least one oxidation dye precursor of a coupler type, at least one ether compound of xylitol and, based on the weight of oxidation dyeing agent, zero to less than 0.1% by weight of peroxide compounds, wherein the oxidation dyeing agent preferably has a pH value in the range of 8 to 11, in particular in the range of 8.5 to 10.7, particularly preferably in the range of 9 to 10.3, most preferably 9.5 to 9.7, each measured at a temperature of 22° C. | 2019-06-20 |
20190183762 | COMPOSITION FOR LIGHTENING OR DYEING KERATIN FIBERS WITH A LOW AMOUNT OF ALKALIZING AGENT - An agent for dyeing keratin fibers comprises a composition A comprising at least one alkalizing agent, at least one oxidative dye precursor, at least one surfactant and at least one fatty substance free of carboxylic acid groups and a composition B comprising at least one oxidizing agent and at least one surfactant. The concentration of fatty substances free of carboxylic acid groups after mixing composition A and composition B is at least 20% by weight relative to the total weight of the mixed composition A and B. The concentration of alkalizing agent after mixing composition A and composition B is not more than | 2019-06-20 |
20190183763 | METHOD FOR HOMOGENOUSLY DYEING KERATINOUS FIBERS - The object of the present disclosure is a method for dyeing human hair which is adapted to the differing degrees of damage along the length of the hair fiber and achieves more homogenous coloring results. | 2019-06-20 |
20190183764 | HAIR TREATMENT AGENT CONTAINING SULFATED OR SULFONATED OILS AND AMIDOAMINES - The subject matter of the present disclosure is a hair treatment agent which, based on the weight of the entire agent, contains
| 2019-06-20 |
20190183765 | Amino Acid Carbamate Complexes - Disclosed herein are amino acid carbamate complexes, methods of synthesis thereof, oral care compositions comprising the same, and methods of making and using thereof. | 2019-06-20 |
20190183766 | Dentifrice Comprising Zinc-Amino Acid Complex - Disclosed herein are dentifrices comprising a zinc amino acid halide, which provide a precipitate of zinc oxide upon use with dilution with water and/or saliva. Methods of making and using the dentifrices are also provided. | 2019-06-20 |
20190183767 | Sunscreen Compositions - Sunscreen compositions containing bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and zinc oxide, especially non-nano zinc oxide materials, with synergistic effects on enhancing in vivo sun protection factor (SPF) and UVA protection factor (PFA) values, and methods of preparation and applications thereof are disclosed. | 2019-06-20 |
20190183768 | TONING SHAMPOO WITH IMPROVED COLOUR PERFORMANCE - The present disclosure concerns an agent for colouring keratinous fibres, in particular human hair, containing, in a cosmetic support,
| 2019-06-20 |
20190183769 | TINTING SHAMPOOS - The disclosure relates to an agent for the dyeing of keratinic fibers, in particular human hair, containing in a cosmetic carrier | 2019-06-20 |
20190183770 | COMPOUNDS AND COMPOSITIONS FOR USE - The present disclosure provides compositions which may be used to augment, supplement and/or replace the products of certain UV sensitive/dependent processes. In particular, the disclosure provides sunscreen compositions which avoid problems associated with prior art sunscreen compositions which inhibit the natural progression of certain in vivo sunlight/UV dependent processes including processes which result in Nitric Oxide/Vitamin D production in the skin. | 2019-06-20 |
20190183771 | COSMETIC COMPOSITION AND METHODS OF USE THEREOF - Disclosed is a topical skin composition. The composition can include 60 to 85% by weight of water, 4 to 10% by weight of isodecane, 0.5 to 4% by weight of caprylic/capric triglyceride, 0.2 to 3% by weight of dimethicone, 0.2 to 3% by weight of cetyl alcohol, 0.2 to 3% by weight of stearic acid, 0.1 to 2% by weight of arachidyl alcohol, 0.05 to 2% by weight of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.05 to 2% by weight of behenyl alcohol, 0.05 to 2% by weight of isohexadecane, 0.01 to 1% by weight of arachidyl glucoside, and 0.01 to 1% by weight of acrylates/C10-30 alkyl acrylate crosspolymer, polysorbate 60. | 2019-06-20 |
20190183772 | COSMETIC PRODUCTS FOR THE TEMPORARY RESHAPING OF KERATINOUS FIBERS WITH LONG-LASTING HOLD - The present disclosure relates to a cosmetic product for the temporary reshaping of keratinous fibers, particularly human hair, containing potato starch and dehydroxanthan gum. | 2019-06-20 |
20190183773 | COSMETIC AGENT FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS WITH STARCH - The present disclosure relates to a cosmetic agent containing potato starch for the temporary shaping of keratinic fibers, in particular human hair. In an alternate embodiment, a method of temporarily shaping keratinic fibers is provided. The method includes applying a cosmetic agent to the keratinic fibers, wherein the cosmetic agent comprises potato starch. | 2019-06-20 |
20190183774 | COSMETIC AGENT FOR TEMPORARILY RESHAPING KERATINOUS FIBRES WITH FILM FORMER - The application describes a cosmetic agent for temporarily reshaping keratin fibres, in particular human hair, comprising a film former and a cosmetic carrier, wherein the film former comprises
| 2019-06-20 |
20190183775 | NON-COMEDOGENIC AND NON-ACNEGENIC HAIR AND SCALP CARE FORMULATIONS AND METHOD FOR USE - An improved hair and scalp treatment composition comprising a hair care product wherein the improvement comprises reducing the comedogenicity thereof by excluding therefrom comedogenic elements having a Fulton scale grade greater than 2. | 2019-06-20 |
20190183776 | THICKENED, CLEAR SALT-RICH COMPOSITION, METHOD FOR LIGHTENING SAME, AND USE THEREOF IN COSMETICS - Disclosed is a composition including (per 100% weight): a) 90 wt.-% to 99.0 wt.-% water including, in dissolved form, 0.002 mol/L to 0.1 mol/L of at least one salt of ammonium cation or of a monovalent or multivalent metal cation with an organic or inorganic anion; b) 0.5 wt.-% to 5 wt.-% of a crosslinked anionic polyelectrolyte; and c) 0.5 wt.-% to 5 wt.-% of a compound having formula (II): R | 2019-06-20 |
20190183777 | LOW VISCOSITY, COMPACT SHAMPOO COMPOSITION CONTAINING SILICONE POLYMERS - A clear shampoo composition containing a silicone emulsion and a detersive surfactant. The silicone emulsion contains one or more silicone polymers that can be a polyorganosiloxane compound containing one or more quaternary ammonium groups, silicone blocks comprising between about 99 and about 199 siloxane units on average, at least one polyalkylene oxide structural unit; and at least one terminal ester group. | 2019-06-20 |
20190183778 | LOW VISCOSITY CONDITIONER COMPOSITION CONTAINING SILICONE POLYMERS - A concentrated conditioner composition to be dispensed as a foam from a foam dispenser, wherein the composition comprises one or more silicone polymers. The silicone polymers is a polyorganosiloxane compound containing one or more quaternary ammonium groups, silicone blocks comprising between about 99 and about 199 siloxane units on average, at least one polyalkylene oxide structural unit; and at least one terminal ester group. | 2019-06-20 |
20190183779 | NAIL COATING SYSTEM - The present technology provides a nail coating system suitable for improving the nail plate to which it is applied. The nail coating system includes two components—an oil-based serum and a base composition. In use, the oil-based serum may be applied directly to a nail plate without first cleaning the nail plate with alcohol and/or acetone. The oil-based serum coat may fill in any cracks and crevices in the nail plate and restoring sebum and water on the nail plate. After the oil-based serum layer is buffed into the nail, the base composition may be applied for the oil-based serum coat. After the base composition dries, a user may apply a top coat, a tinted nail polish, a perfector product, etc. The resulting nail plate has improved features and restored natural sebum and water levels in the nail plate. | 2019-06-20 |
20190183780 | Taurine and Aloe Synergistic Anti-Irritant Compositions and Methods - Personal care compositions containing active ingredients and an anti-irritant combination of aloe and taurine are disclosed. Methods of preparing the personal care composition and uses of the personal care composition are also disclosed. | 2019-06-20 |
20190183781 | SKIN CARE FORMULATION - There is provided a skin care formulation for transdermal administration of a component of a blood product, the formulation comprising a blood product, a transdermal carrier; and a liposomal base, wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base. | 2019-06-20 |
20190183782 | PROBIOTIC INFUSED DENTAL FLOSS - A disclosure is provided for a method of probiotic microorganism infusion of an interdental hygienic device whereby the microorganisms may be released upon device usage (dental flossing) conferring an additional benefit to interdental hygienic devices. | 2019-06-20 |
20190183783 | SKIN CARE COMPOSITION - Disclosed is a skin care composition with a carrier substance and a proportion of lactic acid bacteria or their metabolic products. | 2019-06-20 |
20190183784 | METHOD OF PREPARING A PHARMACEUTICAL COMPOSITION - The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound. | 2019-06-20 |
20190183785 | NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR - The present invention describes novel nanoparticle compositions, and systems and methods utilizing them for treating disorders and/or conditions. Methods generally involve administering nanoparticle compositions (e.g., nanoparticle compositions comprising at least one known therapeutic agent and/or independently active biologically active agent; and/or empty nanoparticle compositions) to a subject in need thereof. | 2019-06-20 |
20190183786 | COMPOSITIONS FOR SENSITIVE SKIN - Disclosed are compositions and methods for their use that include a combination of hydrolyzed algin, escin, | 2019-06-20 |
20190183787 | TOPICAL THERAPY FOR THE TREATMENT OF SKIN MALIGNANCIES USING NANOPARTICLES OF TAXANES - Disclosed are methods useful for the topical therapeutic treatment of skin malignancies including skin cancers and cutaneous metastases using compositions containing nanoparticles of paclitaxel or other taxanes. | 2019-06-20 |
20190183788 | ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODY COMBINATIONS - Methods of administering immunoconjugates that bind to CD37 (e.g., IMGN529) in combination with antibodies that bind to CD20 are provided. The methods comprise administering an anti-CD37 immunoconjugate (e.g., IMGN529) and an anti-CD20 antibody to a person in need thereof, for example, a cancer patient. | 2019-06-20 |
20190183789 | INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF - The present invention provides methods of delivering a composition comprising nanoparticles that comprise a macrolide and an albumin by directly injecting the nanoparticle composition into the blood vessel wall or the tissue surrounding the blood vessel wall. The methods can be used for inhibiting negative remodeling or vascular fibrosis in the blood vessel and are useful for treating various diseases. | 2019-06-20 |
20190183790 | SINGLE DOSE NON-ADJUVANTED CUTANEOUS TETANUS VACCINE AND USES THEREOF - A method for preventing or treating tetanus infection in a subject, comprising administering a non-adjuvanted tetanus toxoid vaccine to the skin. The vaccine can be delivered by intradermal injection or microneedle patch and does not require cold storage. | 2019-06-20 |
20190183791 | SHORT DURATION DEPOT FORMULATIONS - Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, depot gel compositions that can be injected into a desired location and which can provide controlled release of a beneficial agent over a short duration of time. The compositions include a low molecular weight biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent. | 2019-06-20 |
20190183792 | COMPOSITION AND METHOD FOR TREATING HERPESVIRUS IN MAMMALS - Disclosed is a composition and method for ocular infection, including treating ocular herpesvirus infection, including feline herpesvirus (FHV), canine herpesvirus (CHV), and equine herpesvirus (EHV), where the composition includes povidone-iodine and DMSO. | 2019-06-20 |
20190183793 | COLCHICINE DRUG-TO-DRUG INTERACTIONS - The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided. | 2019-06-20 |
20190183794 | COLCHICINE DRUG-TO-DRUG INTERACTIONS - The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided. | 2019-06-20 |
20190183795 | Solid Solution Compositions and Use in Chronic Inflammation - The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions. | 2019-06-20 |
20190183796 | COMBINATION TAXOID NANOEMULSION WITH IMMUNOTHERAPY IN CANCER - A composition of an omega-3 polyunsaturated fatty acid (PUFA)-taxoid conjugate formulated in an oil-in-water nanoemulsion (NE) drug delivery system in combination with an immune-oncology (IO) agent to enhance therapeutic efficacy in refractory cancers, such as PDAC. A method of treating cancer, by administering an effective amount of a pharmaceutical composition including an omega03 PUFA-taxoid conjugate in combination with an IO agent encapsulated in an NE drug delivery system to a subject in need of treatment, and treating cancer. | 2019-06-20 |
20190183797 | BETULIN-CONTAINING WATER-IN-OIL FOAMS AND COMPOSITIONS THEREOF - The present disclosure relates to foams comprising outer birch bard extracts. Stable compositions thereof, as well as methods of producing such foams, and methods of using of such foams are also described herein. The foams of the present disclosure contain triterpenes, which are known to improve wound healing. | 2019-06-20 |
20190183798 | METHOD FOR TREATING TUMOR - A method of treating a subject having or suspected of having a solid tumor, comprises administering to the subject an effective amount of a liposome-encapsulated drug, and applying an amplitude-modulated (AM) radiofrequency radiation to the solid tumor. | 2019-06-20 |
20190183799 | AMPHIPHILIC MOLECULES LAYERS - The disclosure relates to a layer comprising at least one hydrophilic part and at least one hydrophobic part, the layer comprising self-assembled amphiphilic molecules polymerized with each other on both the hydrophilic part and the hydrophobic part of the layer; a detecting device comprising a substrate and the above-mentioned layer; and a liposome, a micelle, transport system for a substance and a biomimetic system comprising the above-mentioned layer. The disclosure also relates to a process for producing a layer, the process comprising: providing amphiphilic molecules; allowing sufficient time for the amphiphilic molecules to self-assemble and form at least one hydrophilic part and at least one hydrophobic part of the layer; polymerizing the self-assembled amphiphilic molecules with each other on both the hydrophilic part and the hydrophobic part of the layer. | 2019-06-20 |
20190183800 | TRANSMEMBRANE PH-GRADIENT POLYMERSOMES AND THEIR USE IN THE SCAVENGING OF AMMONIA AND ITS METHYLATED ANALOGS - The present invention provides polymersomes comprising non-biodegradable amphiphilic block-copolymers and their enteral (e.g., oral) or topical use in the treatment of an ammonia or ammonia methylated analog-associated disease or disorder or symptom thereof (e.g., hyperammonemia or trimethylaminuria). More particularly, it provides a polymersome comprising (a) a membrane, which comprises a block copolymer of poly(styrene) (PS) and poly(ethylene oxide) (PEO), wherein the PS/PEO molecular weight ratio is higher than 1.0 and lower than 4.0; and (b) a core which encloses an acid. It also provides a method of making the polymersome comprising mixing the copolymer-containing organic solvent phase with an aqueous phase containing the acid. | 2019-06-20 |
20190183801 | METHOD FOR THE PRODUCTION OF A DOSAGE FORM - A method is described for producing a dosage form and granules including surface-reacted calcium carbonate. Also described, are tablets and/or capsules obtained by the method. Methods using such a surface-reacted calcium carbonate, and a dosage form comprising the granules are also described. Further, methods of using the granules, or the tablets and/or capsules, or the dosage form in a pharmaceutical product, a nutraceutical product, an agricultural product, a cosmetic product, a home product, a food product, a packaging product and a personal care product are also described. A pharmaceutical product, a nutraceutical product, an agricultural product, a cosmetic product, a home product, a food product, a packaging product and a personal care product including the granules, or the tablets and/or capsules, or the dosage form are also described. | 2019-06-20 |
20190183802 | ACTIVE SELF-HEALING BIOMATERIAL SYSTEM - Methods and compositions are provided that load and encapsulate an agent, such as a protein, in a porous self-healing polymer. A delivery system includes a porous self-healing polymer, an ionic affinity trap within the pores of the self-healing polymer, and an agent associated with the ionic affinity trap. Methods of encapsulating an agent in a polymer include providing a porous self-healing polymer comprising an ionic affinity trap within the pores. The polymer is incubated with an agent having an affinity for the ionic affmity trap. At least a portion of the pores in the polymer are then healed. Active encapsulation of macromolecules at low concentrations may be achieved due to affinity of the agent for the ionic affinity trap within the pores. | 2019-06-20 |
20190183803 | FREEZE-DRIED FORMULATIONS OF ANTIBACTERIAL PROTEIN - A freeze-dried formulation includes an antibacterial protein having killing activity specific to at least one of or all following species: | 2019-06-20 |
20190183804 | SOLID DRUG STORAGE APPARATUS, FORMULATIONS AND METHODS OF USE - Embodiments of the invention provide drug packaging and methods for producing drug packaging which can be sealed at room temperature and/or without the need for elevated temperatures above room temperature. Many embodiments provide drug packaging comprising pierceable tubing having a capsule shape (also referred to herein as a pierceable capsule and/or pierceable drug capsule) containing a solid drug such as a drug pellet and methods for producing pierceable drug capsules which can be sealed at room temperature. Embodiments are particularly useful for the packaging and delivery of drugs used in implantable drug delivery devices as well as packaging of drugs that are easily thermally degraded. | 2019-06-20 |
20190183805 | PHARMACEUTICAL COMPOSITION COMPRISING POMALIDOMIDE - The present invention relates to a pharmaceutical composition comprising pomalidomide, maltodextrin and a filler, wherein the weight ratio of maltodextrin to filler ranges from 1:1 to 1:2. The invention further relates to the use of said pharmaceutical composition as medicament in the treatment of multiple myeloma. | 2019-06-20 |
20190183806 | PACKAGED MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED STABILITY - Packaged formulations of gamma-hydroxybutyrate having improved dissolution and chemical stability, packaging for supporting said stability, and therapeutic uses thereof. | 2019-06-20 |
20190183807 | Therapeutic Agent Release System - A therapeutic agent release system may be provided. The therapeutic agent release system may include a plurality of polymer shells having a diameter of about 50-200 nanometers. The therapeutic agent release system may further include a bio-active therapeutic agent encapsulated by each of the polymer shells and being configured to heal an injury and increase a wound electric signal of the injury thereby increasing a healing rate of the injury. Each of the polymer shells may have a degradation profile configured to control a release of the bio-active therapeutic agent through the polymer shell to the injury over a predetermined period of time. | 2019-06-20 |
20190183808 | Methods and Compositions Particularly for Treatment of Attention Deficit Disorder - There is described, inter alia, a coated bead comprising: (a) a granule; (b) a first layer coated over the granule, the first layer comprising a first amount of an active pharmaceutical ingredient comprising a central nervous system stimulant; and (c) a second layer coated over the first layer, the second layer being present in an amount sufficient to substantially delay release of the active pharmaceutical ingredient in the first layer until after the coated bead reaches a distal intestine portion of a subject to whom the coated bead is administered; and (d) the third layer coated over the second layer, the third layer comprising a second amount of the active pharmaceutical ingredient, the third layer being configured to permit substantially immediate release of the active pharmaceutical ingredient comprised therein. Embodiments related to a solid oral pharmaceutical composition are also described. | 2019-06-20 |
20190183809 | Methods and Compositions Particularly for Treatment of Attention Deficit Disorder - There is described, inter alia, a coated bead comprising: (a) a granule; (b) a first layer coated over the granule, the first layer comprising a first amount of an active pharmaceutical ingredient comprising a central nervous system stimulant; and (c) a second layer coated over the first layer, the second layer being present in an amount sufficient to substantially delay release of the active pharmaceutical ingredient in the first layer until after the coated bead reaches a distal intestine portion of a subject to whom the coated bead is administered; and (d) the third layer coated over the second layer, the third layer comprising a second amount of the active pharmaceutical ingredient, the third layer being configured to permit substantially immediate release of the active pharmaceutical ingredient comprised therein. Embodiments related to a solid oral pharmaceutical composition are also described. | 2019-06-20 |
20190183810 | TRANSDERMAL ADHESIVE COMPOSITION COMPRISING A VOLATILE LIQUID THERAPEUTIC AGENT HAVING LOW MELTING POINT - Methods, compositions, and devices for transdermally administering an active agent such as memantine are provided. | 2019-06-20 |
20190183811 | COMPOSITION CONTAINING SQUALENE FOR IMPROVING MUSCLE FUNCTION AND PREVENTING MUSCLE DAMAGE - The present invention relates to a composition for preventing, treating, or ameliorating muscle disease or regenerating damaged muscles, comprising squalene. More specifically, the squalene of the present invention increases expression of proteins which are associated with muscle protein synthesis and muscle mass increase in muscle cells, inhibits, at an mRNA level, expression of enzymes involved in muscle protein degradation, and has an effect of rapidly restoring damaged muscles. In addition, the present invention relating to a natural product can be safely used without side effects, and thus can be used as medicines, foods, or cosmetics. | 2019-06-20 |
20190183812 | Compounds For The Treatment Of Neuromuscular Disorders - The present invention relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein preferably inhibit the CIC-1 ion channel. | 2019-06-20 |
20190183813 | THERAPEUTIC COMPOSITIONS FOR TREATING PANCREATIC CANCER - The present invention is directed to therapeutic compositions for treating pancreatic cancer comprising a cyclohexnone compound and one or more anti-cancer agents. | 2019-06-20 |
20190183814 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING SKIN CONDITIONS - This disclosure relates to new compositions and methods for treating skin conditions as a result of sun damage. In one embodiment this disclosure pertains to new compositions for treating or preventing sunburns, skin damage, and/or harm from radiation, such as UV radiation. | 2019-06-20 |
20190183815 | TIME RELEASE OF CoQ10 - Compositions are provided that provide an extended release of CoQ10. In certain aspects, the extended release CoQ10 composition includes an extended release bead multiparticulate comprising CoQ10 configured to release the CoQ10 over a period of 4 hours or more. In other aspects, the extended release CoQ10 composition includes an extended release lipid multiparticulate comprising CoQ10 configured to release the CoQ10 over a period of 4 hours or more. | 2019-06-20 |
20190183816 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT - The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these compounds. The subject compositions are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease. | 2019-06-20 |
20190183818 | Inhibition of Sphingosine 1-Phosphate Receptor for Treatment and Prevention of Lymphedema - Provided are methods of and compositions for treating or preventing lymphedema by administering a sphingosine 1-phoshate receptor modulator. | 2019-06-20 |
20190183819 | METHODS AND SYSTEMS FOR TREATING VITILIGO USING PHLOROGLUCINOL AND RELATED COMPOSITIONS - The present invention generally relates to systems and methods for treating vitiligo and related conditions. In some embodiments, a composition comprising phloroglucinol and/or related compounds, such as benzenetriols, phlorotannins, or algae extract, is applied to the skin. The composition may be formulated for application to the skin of a subject, for instance, as a gel, lotion, cream, ointment, soap, or stick. The composition may also comprise a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present as a liquid crystal, and/or in liposomes, micelles, or other vesicles. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like. | 2019-06-20 |
20190183820 | NON-RACEMIC BETA-HYDROXYBUTYRATE COMPOUNDS AND COMPOSITIONS ENRICHED WITH THE S-ENANTIOMER AND METHODS OF USE - Ketogenic compositions including a non-racemic mixture of beta-hydroxybutyrate (BHB) enriched with the S-enantiomer are formulated to control ketone body levels in a subject. The non-racemic mixture of BHB is enriched with the S-enantiomer to modulate the effect of ketone bodies in the subject and control the rate at which ketosis is achieved. In some aspects a composition for controlling ketone body level in a subject contains a dietetically or pharmaceutically acceptable carrier and a non-racemic mixture of S-beta-hydroxybutyrate and R-beta-hydroxybutyrate, wherein the non-racemic mixture contains from about 52% to 99% by enantiomeric equivalents of S-beta-hydroxybutyrate enantiomer and from about 48% to about 1% by enantiomeric equivalents of R-beta-hydroxybutyrate enantiomer. | 2019-06-20 |
20190183821 | NON-RACEMIC BETA-HYDROXYBUTYRATE COMPOUNDS AND COMPOSITIONS ENRICHED WITH THE S-ENANTIOMER AND METHODS OF USE - Ketogenic compositions including a non-racemic mixture of beta-hydroxybutyrate (BHB) enriched with the S-enantiomer are formulated to control ketone body levels in a subject. The non-racemic mixture of BHB is enriched with the S-enantiomer to modulate the effect of ketone bodies in the subject and control the rate at which ketosis is achieved. In some aspects a composition for controlling ketone body level in a subject contains a dietetically or pharmaceutically acceptable carrier and a non-racemic mixture of S-beta-hydroxybutyrate and R-beta-hydroxybutyrate, wherein the non-racemic mixture contains from about 52% to 99% by enantiomeric equivalents of S-beta-hydroxybutyrate enantiomer and from about 48% to about 1% by enantiomeric equivalents of R-beta-hydroxybutyrate enantiomer. | 2019-06-20 |
20190183822 | Compositions and Methods of Use of Beta-Hydroxy-Beta-Methylbutyrate (HMB) FOR MODULATING AUTOPHAGY AND LIPOPHAGY - The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to modulate autophagy and lipophagy. HMB is also administered to treat, prevent, inhibit, slow or reduce autophagy-mediated conditions or diseases. | 2019-06-20 |
20190183823 | STABLE IBUPROFEN INJECTABLE COMPOSITION - The present invention relates to a composition for injectable formulation, the composition comprising:- An aqueous solution of ibuprofen and arginine with a molar ratio of ibuprofen:arginine comprised between 1:1.1 and 1:2.1;- An aqueous solution of a diuretic compound comprising between 3.9% and 4.35% w/v of the diuretic compound. The present invention also concerns a pharmaceutical composition comprising said composition and the use of said composition and said pharmaceutical composition. | 2019-06-20 |
20190183824 | USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS - A method of treating a movement abnormality associated with the pathology of a neurological movement disorder, such as Parkinson's disease or Restless Leg(s) Syndrome by administering a therapeutically effective amount of a PDE7 inhibitory agent. An aspect of the invention provides for the administration of a PDE& inhibitory agent in conjunction with a dopamine agonist or precursor, such as levodopa. In another aspect of the invention, the PDE7 inhibitory agent may be selective for PDE7 relative to other molecular targets (i) known to be involved with the pathology of Parkinson's disease or (ii) at which other drug(s) that are therapeutically effective to treat Parkinson's disease act. | 2019-06-20 |
20190183825 | RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY - Disclosed herein are methods for culturing CAR-modified immune cells with at least one Retinoic Acid Receptor and/or Retinoid X Receptor active agent. | 2019-06-20 |
20190183826 | D-Serine Treatment for Neurological Disorders that Cause Seizures - Methods of treatment using D-serine to target brain cells expressing GluN3 subunit-containing triheteromeric NMDARs are disclosed. The methods include inhibiting calcium ion uptake by brain cells, treating epilepsy, and treating seizures by artificially administering D-serine. | 2019-06-20 |
20190183827 | COMPOSITION FOR IMPROVING MUSCULAR ENDURANCE - Compositions which contain one or more kinds of essential amino acids other than leucine and not less than 35 mol % of leucine, relative to the total content of essential amino acids, are useful for improving muscular endurance, can be ingested safely, and can efficiently improve muscular endurance conveniently in a short period of time. | 2019-06-20 |
20190183828 | Composition for Promoting Ketone Body Production - An object of the present invention is to provide a novel composition for promoting ketone body production. The present invention provides a composition for use in promoting ketone body production, comprising one or more amino acid(s) selected from the group consisting of citrulline, leucine, cysteine, taurine, glutamine and aspartic acid. The composition according to the present invention may further comprise either or both of a medium-chain fatty acid and a medium-chain fatty acid ester. | 2019-06-20 |
20190183829 | Compositions and Methods for Lowering Triglycerides without without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 2019-06-20 |
20190183830 | OMEGA-3 FATTY ACID ARTICLES OF MANUFACTURE, AND METHODS AND APPARATUS FOR MAKING SAME - Embodiments of the present invention are directed to methods, apparatus and articles of manufacture that feature omega- | 2019-06-20 |